The Provincial Defense Council assured that the refrigeration equipment to keep the doses at the required temperature and the logistics to transport the vaccines to the clinical sites are already guaranteed.
"Health workers will check patients for one hour, to make sure that no one presents strong adverse reactions," Roca added and explained that over 4,000 Medical students will take part in this process.
Abdala is one of five COVID-19 vaccines being developed in the country, which plans to immunize 70 percent of its population by August 2021.
This homegrown vaccine concluded its Phase III clinical trials on May 1 in the provinces of Santiago de Cuba, Guantanamo, and Granma. According to experts, Abdala is a very safe vaccine.